2 Jun 2020 10:07
Circassia Signs Equity Finance Facility For Up To GBP5 Million
Circassia Signs Equity Finance Facility For Up To GBP5 Million
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CIR.L Share News (CIR)
CIR Share
Price
CIR Share
News
CIR Share
Chat
CIR Share
Trades
CIR
Live RNS
CIR Share
Charts
CIR Broker
Ratings
CIR Directors
Deals
CIR Financial
Diary
CIR
Fundamentals
CIR Short
Positions
CIR
Media
CIR.L Information
- There is currently no data for CIR
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.15 Apr 2020 11:32
Another Circassia Investor Agrees To Approve Termination Of Astra JV
Another Circassia Investor Agrees To Approve Termination Of Astra JV
Read more14 Apr 2020 15:59
UK DIRECTOR DEALINGS SUMMARY: RHI Magnesita Chair Spends EUR8 Million
UK DIRECTOR DEALINGS SUMMARY: RHI Magnesita Chair Spends EUR8 Million
Read more9 Apr 2020 11:23
UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders
UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders
Read more9 Apr 2020 10:52
Circassia Wants To Terminate AstraZeneca Deal And Transfer Drug Rights
Circassia Wants To Terminate AstraZeneca Deal And Transfer Drug Rights
Read more10 Jan 2020 15:52
CIP Merchant Capital Acquires 3.4% Stake In Circassia Pharmaceuticals
CIP Merchant Capital Acquires 3.4% Stake In Circassia Pharmaceuticals
Read more9 Jan 2020 12:03
Circassia shares rise as it flags 'significant' revenue growth
(Sharecast News) - Respiratory disease-focussed pharmaceutical company Circassia Pharmaceuticals updated the market on its trading for the year ended 31 December on Thursday, announcing that it expected revenues for the year to fall in the mid-range of its previously issued guidance of between £60m and £65m.
Read more9 Jan 2020 09:20
Circassia Pharmaceuticals Expects 2019 Revenue Growth; Names New CFO
Circassia Pharmaceuticals Expects 2019 Revenue Growth; Names New CFO
Read more3 Jan 2020 14:41
Adams increases stake in Circassia
(Sharecast News) - Adams announced on Friday that, on 2 January, it purchased an additional 2,400,000 ordinary shares in Circassia on the AIM market, at an average price of 19p per share, for a total cash consideration of £0.46m.
Read more3 Jan 2020 09:50
Adams Increases Stake In Circassia Pharmaceuticals
Adams Increases Stake In Circassia Pharmaceuticals
Read more19 Dec 2019 16:44
Circassia shares plunge as its partner terminates agreement
(Sharecast News) - Specialty biopharmaceutical company Circassia Pharmaceuticals updated the market on its licensing agreement with BeyondAir, previously AIT Therapeutics, on Thursday.
Read more19 Dec 2019 09:27
Circassia Pharmaceuticals Notes Terminated Agreement With BeyondAir
Circassia Pharmaceuticals Notes Terminated Agreement With BeyondAir
Read more19 Dec 2019 08:38
LONDON MARKET OPEN: Listless Start To Trade; BoE To Keep Rates Steady
LONDON MARKET OPEN: Listless Start To Trade; BoE To Keep Rates Steady
Read more19 Dec 2019 07:38
LONDON MARKET PRE-OPEN: Higher Call; Endeavour-Centamin Tussle Ongoing
LONDON MARKET PRE-OPEN: Higher Call; Endeavour-Centamin Tussle Ongoing
Read more5 Dec 2019 10:47
Circassia Pharmaceuticals CEO Retires; Reiterates 2019 Guidance
Circassia Pharmaceuticals CEO Retires; Reiterates 2019 Guidance
Read more